What is Tenax Therapeutics Inc?
, a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 73.77M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 47,500 shares $71k |